The observed difference between all the studies could be explained by a number of factors, including heterogeneity in head and neck tumour populations, biased selection of patients and method of detection of VEGF-A protein levels, the latter being one of the most critical aspect in this type of retrospective study. Here, VEGFA is linked to head and neck neoplasm.